Search
-
News
Memorial Sloan Kettering Cancer Center (MSK) today celebrates its 26th year of the "holiday hallway." Each year during December, MSK’s carpenters, toolmakers, locksmiths, electricians, and painters construct a winter wonderland in the basement hallway of MSK for patients, families, and staff to visit and enjoy. The decades-long tradition brings joy and cheer to all and has grown in size and detail year after year. The “holiday hallway” is a labor of love for MSK’s Facilities staff, who give of themselves to create the magical MSK tradition.
… Thursday, December 12, 2019 Today Show host, Hoda Kotb, takes a selfie with MSK’s Department of Facilities in MSK’s Holiday Hallway Today Show host, Hoda Kotb, takes a selfie with MSK’s Department of Facilities in MSK’s Holiday Hallway Memorial Sloan Kettering Cancer Center (MSK) today celebrates its
-
News
Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers questions about diet, supplements, and what the research shows.
… Monday, September 30, 2024 Magnesium is having a big moment, as its boosters take to social media to tout the mineral’s potential to do everything from relieve anxiety and facilitate sleep to lower blood pressure and cure constipation. Naturally abundant in certain foods and widely available in supplement
-
News
Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology.
… Monday, June 3, 2024 Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented several promising studies on treating rare solid tumors at the annual meeting of the American Society of Clinical Oncology (ASCO). The results of clinical trials focused on mesothelioma and three types of soft-tissue
-
News
Learn how a new treatment approach using high-dose radiation has given hope to people with inoperable tumors.
… Tuesday, October 2, 2018 Summary People with liver cancer or pancreatic cancer sometimes have tumors that are too large to be removed through surgery. Conventional radiation doses are not able to control these tumors. A new radiation approach using higher doses can sometimes control large tumors in
-
News
Meet Dario Cortes, who was treated for rectal cancer at Memorial Sloan Kettering and is now back to doing the activities he loves.
… Tuesday, December 18, 2018 VIDEO | 01:02 The stages of colon cancer Video Details Summary Dario Cortes was diagnosed with rectal cancer in 2015. He started chemotherapy and radiation at Memorial Sloan Kettering and had no evidence of disease when he finished treatment. When the cancer returned six months
-
News
Conozca a Dario Cortes, que recibió tratamiento para el cáncer rectal en el Memorial Sloan Kettering y ahora hace las actividades que ama.
… Tuesday, December 18, 2018 VIDEO | 01:02 The stages of colon cancer Video Details Resumen Dario Cortes recibió el diagnóstico de cáncer rectal en 2015. Comenzó quimioterapia y radiación en Memorial Sloan Kettering y no mostraba evidencia de enfermedad cuando terminó el tratamiento. Cuando el cáncer regresó
-
News
In a proof-of-concept study, researchers at MSK and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells.
… Monday, June 3, 2024 In a proof-of-concept study, researchers at Memorial Sloan Kettering Cancer Center (MSK) and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone
-
News
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
… Monday, December 28, 2020 Summary Researchers at Memorial Sloan Kettering have learned how chromosomal instability allows cancer cells to avoid immune defenses and metastasize (spread). The discovery opens up potential new avenues for treatment. Cancer cells are known for spreading genetic chaos. As
-
News
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
… Friday, August 5, 2022 On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial
-
News
Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular.
… Tuesday, April 1, 2014 Summary Several Memorial Sloan Kettering investigators are focused on the study of bacteria, which can teach us much about human health, and about cancer in particular. At first glance, tiny single-celled bacteria could not be more different from humans. But there are many reasons